Omni Healthcare's analgesic drug Cetaprin has a 40% share in the analgesics market in the country of Terrania.Its closest competitor,Febex,has a 25% share in the market,while four other analgesic brands split the remainder.Which statement indicates that Cetaprin is a cash cow according to the BCG matrix?
A) Omni Healthcare often takes money from other strategic business units to support Cetaprin.
B) A customer survey shows that Cetaprin users do not prefer it to other analgesics in the market.
C) The demand for analgesic drugs in the Terranian market is expected to remain stable.
D) Febex is rapidly gaining market share over Cetaprin due to aggressive marketing efforts.
E) The Terranian market for healthcare products is expanding rapidly.
Correct Answer:
Verified
Q5: In the BCG matrix, _ refer to
Q6: Which of the following products would the
Q10: In the BCG growth-share matrix, question marks
Q11: When using a harvest strategy for a
Q12: In the BCG growth-share matrix,stars refer to
Q16: Vertigo is an electronics company. According to
Q16: Kobe Healthcare's analgesic drug Dilophin has a
Q17: Which of the following criteria provides a
Q19: Business portfolio analysis is defined as the
Q34: When a company chooses to divest a
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents